Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $936.11 | 76 | 98.2% |
| Education | $17.51 | 2 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $228.11 | 19 | $0 (2018) |
| Novo Nordisk Inc | $166.23 | 16 | $0 (2018) |
| GlaxoSmithKline, LLC. | $102.46 | 8 | $0 (2018) |
| Purdue Pharma L.P. | $74.63 | 5 | $0 (2018) |
| Lilly USA, LLC | $69.12 | 5 | $0 (2018) |
| Allergan Inc. | $61.60 | 5 | $0 (2018) |
| Sunovion Pharmaceuticals Inc. | $39.77 | 3 | $0 (2017) |
| SANOFI-AVENTIS U.S. LLC | $36.62 | 3 | $0 (2018) |
| PFIZER INC. | $35.35 | 3 | $0 (2017) |
| Janssen Pharmaceuticals, Inc | $27.72 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $16.91 | 1 | AbbVie Inc. ($16.91) |
| 2018 | $205.28 | 17 | AstraZeneca Pharmaceuticals LP ($37.02) |
| 2017 | $731.43 | 60 | AstraZeneca Pharmaceuticals LP ($191.09) |
All Payment Transactions
78 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/09/2021 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: NEUROSCIENCE | ||||||
| 05/22/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $10.88 | General |
| Category: Central Nervous System (CNS) | ||||||
| 05/17/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/03/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), STEGLATRO, STEGLUJAN | Food and Beverage | In-kind items and services | $10.94 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/02/2018 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: DIABETES | ||||||
| 04/18/2018 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.27 | General |
| Category: NEUROSCIENCE | ||||||
| 04/16/2018 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $10.66 | General |
| Category: RESPIRATORY | ||||||
| 04/10/2018 | Novo Nordisk Inc | Victoza (Drug) | Food and Beverage | In-kind items and services | $12.20 | General |
| Category: Diabetes | ||||||
| 03/07/2018 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $10.93 | General |
| Category: RESPIRATORY | ||||||
| 03/06/2018 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Food and Beverage | In-kind items and services | $11.41 | General |
| Category: DIABETES | ||||||
| 02/28/2018 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $10.88 | General |
| Category: RESPIRATORY | ||||||
| 02/27/2018 | Novo Nordisk Inc | Victoza (Drug) | Food and Beverage | In-kind items and services | $11.72 | General |
| Category: Diabetes | ||||||
| 02/13/2018 | Lilly USA, LLC | TRULICITY (Drug), BASAGLAR | Food and Beverage | In-kind items and services | $10.60 | General |
| Category: Diabetes | ||||||
| 02/08/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.25 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/05/2018 | Daiichi Sankyo Inc. | Morphabond ER (Drug) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: Pain Management | ||||||
| 01/23/2018 | Purdue Pharma L.P. | SYMPROIC (Drug), HYSINGLA ER | Food and Beverage | Cash or cash equivalent | $14.92 | General |
| Category: CONSTIPATION | ||||||
| 01/09/2018 | Purdue Pharma L.P. | OXYCONTIN (Drug), SYMPROIC, HYSINGLA ER | Food and Beverage | Cash or cash equivalent | $14.78 | General |
| Category: PAIN MANAGEMENT | ||||||
| 01/04/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.27 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/14/2017 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: Diabetes | ||||||
| 11/30/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.25 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/29/2017 | Lilly USA, LLC | TRULICITY (Drug), BASAGLAR | Food and Beverage | In-kind items and services | $11.25 | General |
| Category: Diabetes | ||||||
| 11/22/2017 | AstraZeneca Pharmaceuticals LP | BYDUREON (Drug) | Education | In-kind items and services | $5.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/15/2017 | Purdue Pharma L.P. | OXYCONTIN (Drug), SYMPROIC, HYSINGLA ER | Food and Beverage | Cash or cash equivalent | $15.95 | General |
| Category: PAIN MANAGEMENT | ||||||
| 11/14/2017 | Novo Nordisk Inc | Victoza (Drug), Xultophy 100/3.6, Tresiba | Food and Beverage | In-kind items and services | $9.08 | General |
| Category: Diabetes | ||||||
| 11/09/2017 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $11.44 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 798 | 1,041 | $788,303 | $74,180 |
| 2022 | 13 | 1,037 | 1,376 | $946,250 | $96,005 |
| 2021 | 13 | 768 | 962 | $557,098 | $67,900 |
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 155 | 170 | $280,990 | $19,961 | 7.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 144 | 172 | $128,140 | $14,061 | 11.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 121 | 265 | $104,145 | $13,920 | 13.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 103 | 116 | $67,164 | $8,711 | 13.0% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 101 | 103 | $109,453 | $7,907 | 7.2% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 67 | 101 | $21,614 | $3,289 | 15.2% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 20 | 20 | $39,365 | $2,974 | 7.6% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 31 | 33 | $18,282 | $1,719 | 9.4% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2023 | 11 | 11 | $12,034 | $815.65 | 6.8% |
| 99283 | Emergency department visit with low level of medical decision making | Facility | 2023 | 12 | 12 | $4,794 | $613.41 | 12.8% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 33 | 38 | $2,322 | $209.21 | 9.0% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 191 | 232 | $384,944 | $30,382 | 7.9% |
| 99219 | Initial hospital observation care per day, typically 50 minutes | Facility | 2022 | 131 | 151 | $105,269 | $13,108 | 12.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 107 | 246 | $91,931 | $12,587 | 13.7% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 91 | 102 | $117,183 | $9,255 | 7.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 77 | 89 | $49,131 | $6,864 | 14.0% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 117 | 135 | $51,271 | $6,565 | 12.8% |
| 99225 | Follow-up observation care per day, typically 25 minutes | Facility | 2022 | 82 | 97 | $36,163 | $4,654 | 12.9% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 60 | 136 | $28,656 | $3,750 | 13.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 33 | 36 | $26,624 | $3,558 | 13.4% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 52 | 53 | $32,654 | $2,654 | 8.1% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 30 | 31 | $16,880 | $2,190 | 13.0% |
| 71045 | X-ray of chest, 1 view | Facility | 2022 | 32 | 34 | $2,824 | $228.10 | 8.1% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 34 | 34 | $2,720 | $210.06 | 7.7% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 85 | 90 | $154,020 | $12,332 | 8.0% |
About Dr. Michelle Weaver, MD
Dr. Michelle Weaver, MD is a Emergency Medicine healthcare provider based in Warren, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/09/2007. The National Provider Identifier (NPI) number assigned to this provider is 1265624621.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michelle Weaver, MD has received a total of $953.62 in payments from pharmaceutical and medical device companies, with $16.91 received in 2021. These payments were reported across 78 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($936.11).
As a Medicare-enrolled provider, Weaver has provided services to 2,603 Medicare beneficiaries, totaling 3,379 services with total Medicare billing of $238,085. Data is available for 3 years (2021–2023), covering 37 distinct procedure/service records.
Practice Information
- Specialty Emergency Medicine
- Other Specialties Family Medicine
- Location Warren, AR
- Active Since 08/09/2007
- Last Updated 06/12/2024
- Taxonomy Code 207P00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1265624621
Products in Payments
- FARXIGA (Drug) $212.20
- Victoza (Drug) $133.98
- TRULICITY (Drug) $69.12
- BREO (Drug) $58.70
- OXYCONTIN (Drug) $43.76
- SOLIQUA (Drug) $36.62
- ANORO (Drug) $32.83
- XARELTO (Drug) $27.72
- VRAYLAR (Drug) $26.30
- Myrbetriq (Drug) $24.38
- VIAGRA (Drug) $24.37
- QULIPTA (Drug) $16.91
- HYSINGLA ER (Drug) $15.95
- UTIBRON (Drug) $15.68
- SYMPROIC (Drug) $14.92
- STIOLTO (Drug) $13.41
- SEEBRI (Drug) $12.70
- Trulance (Drug) $12.51
- Morphabond ER (Drug) $12.50
- BYSTOLIC (Drug) $12.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Warren
Dr. Michael Kobernick, Md, MD
Emergency Medicine — Payments: $90,168
Jessica Shepherd, Do, DO
Emergency Medicine — Payments: $5,750
Dr. Kristy Smith, M.d, M.D
Emergency Medicine — Payments: $3,705
Dr. Patrick Long, Md, MD
Emergency Medicine — Payments: $1,856
Dr. Zachary Veres, Do, DO
Emergency Medicine — Payments: $1,355
Dr. Mae De La Calzada-Jeanlouie, D.o, D.O
Emergency Medicine — Payments: $300.72